Insys, the Opioid Drug Maker, to Pay $225 Million to Settle Fraud Charges

Federal prosecutors accused the company of illegally marketing its powerful fentanyl painkiller and of defrauding government health care programs. KATIE THOMAS https://nyti.ms/2XqNnAp http://bit.ly/2IryIPw The New York Times Health Opioids and Opiates, Drugs (Pharmaceuticals), your-feed-healthcare, Fines (Penalties) June 5, 2019 at 02:00AM